South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's Shoukang Group for its immune-boosting health functional food "NK365" worth 1.8 billion won ($1.4 million).
This agreement marks the first order since both companies entered into the NK365 supply contract on July 4.
Shoukang Group is a company with diverse business experiences in the medical and health services sector in China. It has partnered with JD.com, China's second-largest e-commerce company, to jointly sell health functional foods, cosmetics and other healthcare products.
Starting with a memorandum of understanding (MOU) for investment with Shoukang Group in March this year, NKMax has been working on a collaboration with the Chinese group. From the initial stages of the partnership, the group has already decided to expand its purchases to include NKMax products such as NK Vue Kit, NK365, and super-biotics.
Write to In-hyuk Park at
hyuk@hankyung.com
